 Join webcast now..
"The Artemis solution is critical in supporting the portfolio and life cycle management process at Actelion Pharmaceuticals and in providing the Portfolio Management Board and Life Cycle teams with information and tools to make informed decisions."
Dr. Miriam Halperin-Werli,
Head of Business & Science Affairs, Actelion Ltd.
|
|
Register and join the Portfolio Management in a Biopharmaceutical Company
webcast to see how Actelion’s executive team links their product portfolio and lifecycle management with their corporate strategy and proactively manages their drug candidate portfolio with timely and accurate cost, schedule, risks and benefit information available at multiple levels.
Learn more today about how Actelion is able to:
- Align and prioritize products in the portfolio based on business strategy in order to maximize investment returns
- Maintain an optimum candidate pipeline portfolio by continuously reviewing, analyzing, simulating and restructuring the portfolio in response to change
- Manage capacity by identifying products which are not aligned with the business strategy so that allocated resources can be re-distributed amongst competing products to maximize performance
- Enhance visibility and clarity of their portfolio so that they can make informed, real-time decisions quickly
Actelion Ltd is a biopharmaceutical company with its corporate headquarters in Basel, Switzerland. Founded in late 1997, Actelion is a leading player in innovative science related to the endothelium. Actelion focuses on the discovery, development and marketing of innovative drugs for significant unmet medical needs.
|
Home | Contact us
| Local Sites
